WASHINGTON – At this week's annual meeting of the American Association for Cancer Research, a number of similarities emerged among labs offering cancer gene panels on next-gen sequencing platforms. For example, several groups that offer such services reported that lung cancer is the most common tumor type they see, followed by breast cancer and colorectal cancer. Likewise, these labs all see the same top three mutated genes: TP53, PI3K, and KRAS.